{"url_path":"/sec/qgen/10-k/2026/item-19","section_key":"item-19","section_title":"Item 19 Exhibits","topic":"sec","document":{"doc_type":"20-F","doc_date":"2026-03-20","source_url":"https://www.sec.gov/Archives/edgar/data/1015820/0001015820-26-000018-index.html","accession_number":"0001015820-26-000018","cik":"0001015820","ticker":"QGEN","issuer_name":"QIAGEN N.V.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1015820/0001015820-26-000018-index.html","primary_entity_key":"0001015820","primary_entity_name":"QIAGEN N.V."},"word_count":493,"has_tables":true,"body_markdown":"Item 19.\n\nExhibits\n\nEX\n\n[Exhibit Index](#i3aa25a95177c463e85a564d4fb90a601_373)\n\n[225](#i3aa25a95177c463e85a564d4fb90a601_373)\n\nThis document includes references to certain information contained on QIAGEN's website. The information contained on QIAGEN's website is not incorporated by reference and does not form part of this document.\n\nSection abbreviations:\n\nAPP\n\nAppendices\n\nCG\n\nCorporate Governance\n\nEX\n\nExhibit Index\n\nFS\n\nFinancial Statements\n\nMR\n\nManagement Report\n\nQS\n\nQIAGEN Shares\n\nQIAGEN N.V. | Financial Report 2025\n\n[Management Report](#i3aa25a95177c463e85a564d4fb90a601_88)\n\n[Corporate Governance](#i3aa25a95177c463e85a564d4fb90a601_103)\n\n[Financial Statements](#i3aa25a95177c463e85a564d4fb90a601_157)\n\n[Appendices](#i3aa25a95177c463e85a564d4fb90a601_325)\n\nPage 225\n\nExhibit Index\n\nExhibit No.\n\nDescription\n\nIncorporated by reference\n\nFiled herewith\n\nForm\n\nExhibit\n\nFiling date\n\n[1.1](exhibit11articlesofassocia.htm)\n\nArticles of Association as confirmed by notarial deed as of January 7, 2026 (English translation)\n\n*\n\n[2.1](http://www.sec.gov/Archives/edgar/data/1015820/000101582018000010/exhibit211schuldscheinform.htm)\n\nSchuldscheindarlehensvertrag Form of Loan Agreement dated as of June 19, 2017\n\n20-F\n\n2.11\n\nMarch 6, 2018\n\n[2.](https://www.sec.gov/Archives/edgar/data/1015820/000101582021000018/exhibit212globalbearerbond.htm)2\n\nGlobal Bearer Bond Representing Convertible Bonds due 2027 dated as of December 17, 2020\n\n20-F\n\n2.12\n\nMarch 5, 2021\n\n[2.3](https://www.sec.gov/Archives/edgar/data/1015820/000101582021000018/exhibit213purchaseagentagr.htm)\n\nPurchase Agent Agreement dated as of December 10, 2020\n\n20-F\n\n2.13\n\nMarch 5, 2021\n\n[2.4](https://www.sec.gov/Archives/edgar/data/1015820/000101582021000018/exhibit214subscriptionagre.htm)\n\nSubscription Agreement dated as of December 10, 2020\n\n20-F\n\n2.14\n\nMarch 5, 2021\n\n[2.5](https://www.sec.gov/Archives/edgar/data/1015820/000101582023000012/exhibit2132022schuldschein.htm)\n\nSchuldscheindarlehensvertrag Form of Loan Agreement dated as of July 13, 2022\n\n20-F\n\n2.13\n\nMarch 13, 2023\n\n[2.](https://www.sec.gov/Archives/edgar/data/1015820/000101582023000012/exhibit2142022namensschuld.htm)6\n\nNamensschuldverschreibungen Agreement dated as of August 16, 2022\n\n20-F\n\n2.14\n\nMarch 13, 2023\n\n[2.7](https://www.sec.gov/Archives/edgar/data/1015820/000101582025000027/exhibit27globalbondreprese.htm)\n\nGlobal Bearer Bond Representing Convertible Bonds due 2031 dated as of September 5, 2024\n\n20-F\n\n2.7\n\nMarch 31, 2025\n\n[2.8](https://www.sec.gov/Archives/edgar/data/1015820/000101582025000027/exhibit28purchaseagentagre.htm)\n\nPurchase Agent Agreement dated as of September 4, 2024\n\n20-F\n\n2.8\n\nMarch 31, 2025\n\n[2.9](https://www.sec.gov/Archives/edgar/data/1015820/000101582025000027/exhibit29subscriptionagree.htm)\n\nSubscription Agreement dated as of September 3, 2024\n\n20-F\n\n2.9\n\nMarch 31, 2025\n\n[2.10](https://www.sec.gov/Archives/edgar/data/1015820/000101582020000015/exhibit212descriptiono.htm)\n\nDescription of Securities\n\n20-F\n\n2.12\n\nMarch 2, 2020\n\n[2.11](exhibit211globalbondrepres.htm)\n\nGlobal Bearer Bond Representing Convertible Bonds due 2032 as of September 4, 2025\n\n*\n\n[2.12](exhibit212purchaseagentagr.htm)\n\nPurchase Agent Agreement dated as of August 29,2025\n\n*\n\n[2.13](exhibit213subscriptionagre.htm)\n\nSubscription Agreement dated as of August 28, 2025\n\n*\n\n[4.](http://www.sec.gov/Archives/edgar/data/1015820/000101582015000015/s-8exhibit991qiagennv2014s.htm)1\n\nQIAGEN N.V. 2014 Stock Plan\n\nS-8\n\n99.1\n\nApril 2, 2015\n\n[4.](https://www.sec.gov/Archives/edgar/data/1015820/000101582024000040/exhibit991qiagennv2023stoc.htm)2\n\nQIAGEN N.V. 2023 Stock Plan\n\nS-8\n\n99.1\n\nMay 30, 2024\n\n[8.1](exhibit812025listofsubsidi.htm)\n\nList of Subsidiaries\n\n*\n\n[11.1](https://www.sec.gov/Archives/edgar/data/1015820/000101582024000022/exhibit111qiagennvinsidert.htm)\n\nQIAGEN N.V. Insider Trading Policy\n\n20-F\n\n11.1\n\nMarch 11, 2024\n\n[12.1](exhibit1212025certificatio.htm)\n\nCertification under Section 302; Thierry Bernard, Managing Director and Chief Executive Officer\n\n*\n\n[12.2](exhibit1222025certificatio.htm)\n\nCertification under Section 302; Roland Sackers, Managing Director and Chief Financial Officer\n\n*\n\n[13.1](exhibit1312025certificatio.htm)\n\nCertifications under Section 906; Thierry Bernard, Managing Director and Chief Executive Officer and\n\nRoland Sackers, Managing Director and Chief Financial Officer\n\n*\n\n[15.1](exhibit1512025consentofind.htm)\n\nConsent of Independent Registered Public Accounting Firm\n\n*\n\n[15.2](exhibit1522025consentofind.htm)\n\nConsent of Independent Registered Public Accounting Firm\n\n*\n\n[97.1](https://www.sec.gov/Archives/edgar/data/1015820/000101582024000022/exhibit971qiagennvclawback.htm)\n\nQIAGEN N.V. Clawback Policy\n\n20-F\n\n97.1\n\nMarch 11, 2024\n\n101\n\nInline XBRL Interactive Data File\n\n*\n\n104\n\nCover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)\n\n*\n\nQIAGEN N.V. | Financial Report 2025\n\n[Management Report](#i3aa25a95177c463e85a564d4fb90a601_88)\n\n[Corporate Governance](#i3aa25a95177c463e85a564d4fb90a601_103)\n\n[Financial Statements](#i3aa25a95177c463e85a564d4fb90a601_157)\n\n[Appendices](#i3aa25a95177c463e85a564d4fb90a601_325)\n\nPage 226\n\nSignatures\n\nThe registrant hereby certifies that it meets all of the requirements for filing on Form 20-F and that it has duly caused and\n\nauthorized the undersigned to sign this annual report on its behalf.\n\nQIAGEN N.V.\n\nDated:\n\nMarch 19, 2026\n\nBy:\n\n/s/ Thierry Bernard\n\nThierry Bernard, Chief Executive Officer\n\n/s/ Roland Sackers\n\nRoland Sackers, Chief Financial Officer"}